On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Encore Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Encore Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Encore Pharmaceuticals (United States)?

ScholarIQrecord summary

Encore Pharmaceuticals (United States) is a research organisation in Riverside, United States. OpenAlex records 302 works and 4,272 citations for it. 3 researchers list it as their most recent affiliation.

How many works does Encore Pharmaceuticals (United States) have?

ScholarIQindexed works

Encore Pharmaceuticals (United States) has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Encore Pharmaceuticals (United States) have?

ScholarIQcitation count

Encore Pharmaceuticals (United States) has 4,272 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Encore Pharmaceuticals (United States)?

ScholarIQresearcher count

Encore Pharmaceuticals (United States) has 3 researchers in the ScholarIQ index.

What is the average h-index at Encore Pharmaceuticals (United States)?

ScholarIQavg h-index

Encore Pharmaceuticals (United States) has an average h-index of 67.7 in OpenAlex.

What is the ROR of Encore Pharmaceuticals (United States)?

ScholarIQror

The ROR for Encore Pharmaceuticals (United States) is on the source record.

What is the OpenAlex record for Encore Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Encore Pharmaceuticals (United States) is on the source record.

Who are the most-cited researchers behind Encore Pharmaceuticals (United States)?

ScholarIQtop researchers by citations
1
Thomas N. Chase · Parkinson's Disease Mechanisms and Treatments
477 works35,656 citations
2
John Westwick · Protein Kinase Regulation and GTPase Signaling
322 works17,137 citations
3
Charles M. Baum · Gastrointestinal Tumor Research and Treatment
94 works16,508 citations

What are the most-cited papers on Encore Pharmaceuticals (United States)?

ScholarIQmost cited works
Dopaminergic modulation of cortical function in patients with Parkinson's disease
Venkata S. Mattay, Alessandro Tessitore, Joseph H. Callicott, Alessandro Bertolino, Terry E. Goldberg, Thomas N. Chase, Thomas M. Hyde, Daniel R. Weinberger
Annals of Neurology. 2002403 CitationsOPEN ACCESS
Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
M. Maral Mouradian, J. L. Junecos, Giovanni Fabbrini, J.U. Schlegel, John J. Bartko, Thomas N. Chase
Annals of Neurology. 1988363 Citations
Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease
Alessandro Tessitore, Ahmad R. Hariri, Francesco Saverio Fera, William G. Smith, Thomas N. Chase, Thomas M. Hyde, Daniel R. Weinberger, Venkata S. Mattay
Journal of Neuroscience. 2002291 CitationsOPEN ACCESS

How much of the research on Encore Pharmaceuticals (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
67%
Closed
33%
470M+ articles · free account